Factors associated with selection of targeted therapy in patients with rheumatoid arthritis

OBJECTIVE: Deciding which drug to choose for targeted therapy is an important step in sequential treatment for rheumatoid arthritis (RA). This study aimed to identify factors for selecting Janus kinase inhibitors (JAKis) rather than biologic disease-modifying antirheumatic drugs (bDMARDs) in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yeo-Jin, Cho, Soo-Kyung, Kim, Hyoungyoung, Kim, Hye Won, Nam, Eunwoo, Choi, Chan-Bum, Kim, Tae-Hwan, Jun, Jae-Bum, Bae, Sang-Cheol, Yoo, Dae Hyun, Sung, Yoon Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831325/
https://www.ncbi.nlm.nih.gov/pubmed/36626396
http://dx.doi.org/10.1371/journal.pone.0280234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831325/
https://www.ncbi.nlm.nih.gov/pubmed/36626396
http://dx.doi.org/10.1371/journal.pone.0280234

Ejemplares similares